Cruise sidelines entire US robotaxi fleet

Following California withdrawing Cruise's permit to operate autonomous vehicles in the state, the company announced that it will suspend all…

Neuralink competitor Synchron buys equity stake in the manufacturer

Philip O'Keefe, one of Synchron's patients in the SWITCH clinical trial, was the first person in the world to tweet…